Staphylococci
Authors:
- P.A. LambertPLP.A. Lambert
- T.S.J. ElliottTET.S.J. Elliott
- 1 May 2007
- journal article
- review article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 29, S23-S32
Abstract
No abstract availableKeywords
This publication has 104 references indexed in Scilit:
- High-Level Vancomycin-ResistantStaphylococcus aureusIsolates Associated with a Polymicrobial BiofilmAntimicrobial Agents and Chemotherapy, 2007
- Molecular Characteristics and In Vitro Susceptibility to Antimicrobial Agents, Including the Des-Fluoro(6) Quinolone DX-619, of Panton-Valentine Leucocidin-Positive Methicillin-Resistant Staphylococcus aureus Isolates from the Community and HospitalsAntimicrobial Agents and Chemotherapy, 2006
- Population Pharmacokinetics of Arbekacin in Patients Infected with Methicillin-Resistant Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2006
- Isolates with Low-Level Vancomycin Resistance Associated with Persistent Methicillin-Resistant Staphylococcus aureus BacteremiaAntimicrobial Agents and Chemotherapy, 2006
- Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused byStaphylococcus aureusNew England Journal of Medicine, 2006
- Evaluation of the IDI-MRSA Assay for Detection of Methicillin-Resistant Staphylococcus aureus from Nasal and Rectal Specimens Pooled in a Selective BrothJournal of Clinical Microbiology, 2006
- Spectrum and potency of dalbavancin tested against 3322 Gram-positive cocci isolated in the United States Surveillance Program (2004)Diagnostic Microbiology and Infectious Disease, 2006
- Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000–2004)Diagnostic Microbiology and Infectious Disease, 2005
- Telavancin Versus Standard Therapy for Treatment of Complicated Skin and Soft-Tissue Infections Due to Gram-Positive BacteriaClinical Infectious Diseases, 2005
- Trends in linezolid susceptibility patterns in 2002: Report from the worldwide Zyvox Annual Appraisal of Potency and Spectrum ProgramDiagnostic Microbiology and Infectious Disease, 2005